8-K: ATI Physical Therapy Reports Strong Second Quarter Growth, Exceeds Expectations

ATI Physical Therapy announced robust second-quarter 2024 results, demonstrating significant growth in patient visits, revenue, and adjusted EBITDA.

Summary

• ATI Physical Therapy reported a 9.2% increase in net revenue, reaching $188.1 million in the second quarter of 2024, compared to $172.3 million in the same period last year.
• Net patient revenue grew by 10.1% to $172.8 million, up from $156.9 million in the second quarter of 2023.
• The company saw a 6.4% increase in visits per day (VPD), with 24,921 visits compared to 23,412 in the prior year.
• Rate per visit (RPV) increased by 3.4% to $108.32, up from $104.74 in the second quarter of 2023.
• Adjusted EBITDA surged by 77.5% to $16.6 million, compared to $9.3 million in the second quarter of 2023.
• The adjusted EBITDA margin improved to 8.8%, up from 5.4% in the same period last year.
• ATI closed 2 clinics and divested 4 clinics during the quarter, ending with 878 clinics.
• For the third quarter of 2024, ATI projects net revenue between $180 million and $190 million and adjusted EBITDA between $9 million and $14 million.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial and operational improvements, although risks related to liquidity and debt remain a concern.

Positives

• ATI experienced a significant increase in patient visits, with over 1,500 more visits per day compared to the same period last year.
• The company achieved higher rates per visit due to improved payor contracts and revenue cycle management.
• ATI's strategic focus on people and operations is driving financial progress.
• The company's net loss improved significantly year-over-year.
• ATI's selling, general and administrative expenses decreased by 36.9% due to lower transaction costs and higher legal cost insurance reimbursements.
• Net cash used year-to-date decreased to $3.8 million compared to $45.5 million in the first six months of 2023.
• Investing cash use decreased to $5.2 million year-to-date compared to $10.1 million in the first six months of 2023 due to fewer new clinic openings.

Negatives

• Operating cash used increased to $27.9 million year-to-date compared to $5.3 million in the first six months of 2023, driven by changes in current assets and liabilities.
• PT rent and other per clinic increased by 10.0%, primarily due to higher contract labor usage and third-party services.
• Salaries and related costs increased by 7.6%, mainly due to added clinicians and wage inflation.
• The company closed 2 clinics and divested 4 clinics during the quarter.

Risks

• The company's liquidity position raises substantial doubt about its ability to continue as a going concern.
• There are risks associated with liquidity and capital markets, including the ability to generate sufficient cash flows.
• The company faces risks related to outstanding indebtedness and preferred stock, rising interest rates, and potential increases in borrowing costs.
• ATI is dependent on governmental and third-party private payors for reimbursement, and changes in reimbursement rates could adversely affect financial results.
• The company faces competition in a rapidly changing industry, including competition for skilled physical therapists.
• There are risks associated with the locations of clinics and the potential need to close clinics and incur closure costs.
• The company is subject to extensive regulation and macroeconomic uncertainty.
• There are risks associated with the company's ability to attract and retain talented executives and employees.
• The company faces risks related to dilution of common stock ownership interests.

Future Outlook

ATI expects net revenue to be between $180 million and $190 million and Adjusted EBITDA to be between $9 million and $14 million for the third quarter of 2024. The company anticipates continued growth in patient visits through 2024.

Management Comments

• Sharon Vitti, CEO, stated that the company experienced notable growth in the second quarter, with over 1,500 more patient visits each day compared to the same period last year.
• Sharon Vitti also noted that the company saw higher rates per visit compared to the prior year due to the dedication of their payor and revenue cycle management teams.
• Joe Jordan, CFO, commented that the company's financial progress is a direct result of their strategic focus on people and operations.

Industry Context

The announcement reflects a positive trend in the outpatient physical therapy sector, with ATI demonstrating growth in key metrics. This performance is likely being closely watched by competitors and investors in the healthcare services industry.

Comparison to Industry Standards

• ATI's 6.4% increase in visits per day is a strong indicator of growth, which is favorable compared to industry averages that typically see single-digit growth.
• The 3.4% increase in rate per visit suggests effective revenue cycle management, which is a key focus for healthcare providers.
• The 77.5% increase in Adjusted EBITDA is a significant improvement, indicating better operational efficiency and cost management compared to previous periods and potentially some competitors.
• Companies like Select Medical and U.S. Physical Therapy are key competitors in the outpatient physical therapy space, and ATI's performance will be compared against their results.
• ATI's focus on clinic operational excellence and footprint optimization is a common strategy in the industry to improve profitability and patient access.

Related Party Transactions

• The document mentions 2L Notes due to related parties, at fair value, of $89,997,000 as of June 30, 2024.

Stakeholder Impact

• Shareholders will likely view the improved financial results positively, although concerns about liquidity and debt remain.
• Employees may benefit from the company's growth and focus on people and operations.
• Patients should experience continued access to high-quality care.
• Payors may see improved efficiency and outcomes from ATI's services.

Next Steps

• Management will host a conference call on August 5, 2024, to review the second quarter 2024 financial results.
• The company will continue to execute on its commercial, people, and operations strategies to grow patient visits through 2024.

Key Dates

Keywords

Physical Therapy, Outpatient Care, Financial Results, Revenue Growth, EBITDA, Patient Visits, Healthcare, Clinic Operations, MIPS Rating, Reimbursement Rates